Correlation Between NewAmsterdam Pharma and XTL Biopharmaceutica

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and XTL Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and XTL Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and XTL Biopharmaceuticals Ltd, you can compare the effects of market volatilities on NewAmsterdam Pharma and XTL Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of XTL Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and XTL Biopharmaceutica.

Diversification Opportunities for NewAmsterdam Pharma and XTL Biopharmaceutica

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between NewAmsterdam and XTL is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and XTL Biopharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTL Biopharmaceuticals and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with XTL Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTL Biopharmaceuticals has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and XTL Biopharmaceutica go up and down completely randomly.

Pair Corralation between NewAmsterdam Pharma and XTL Biopharmaceutica

Given the investment horizon of 90 days NewAmsterdam Pharma is expected to generate 1.67 times less return on investment than XTL Biopharmaceutica. But when comparing it to its historical volatility, NewAmsterdam Pharma is 1.83 times less risky than XTL Biopharmaceutica. It trades about 0.04 of its potential returns per unit of risk. XTL Biopharmaceuticals Ltd is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  128.00  in XTL Biopharmaceuticals Ltd on November 28, 2024 and sell it today you would earn a total of  14.00  from holding XTL Biopharmaceuticals Ltd or generate 10.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy98.1%
ValuesDaily Returns

NewAmsterdam Pharma  vs.  XTL Biopharmaceuticals Ltd

 Performance 
       Timeline  
NewAmsterdam Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days NewAmsterdam Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable primary indicators, NewAmsterdam Pharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
XTL Biopharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days XTL Biopharmaceuticals Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain somewhat strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

NewAmsterdam Pharma and XTL Biopharmaceutica Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with NewAmsterdam Pharma and XTL Biopharmaceutica

The main advantage of trading using opposite NewAmsterdam Pharma and XTL Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, XTL Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTL Biopharmaceutica will offset losses from the drop in XTL Biopharmaceutica's long position.
The idea behind NewAmsterdam Pharma and XTL Biopharmaceuticals Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years